The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The Duke of Cambridge is to end his role as an air ambulance pilot and become a full-time Royal, Kensington Palace has announced.
The UN released the before and after images and described the damage, reportedly caused by Islamic State, as 'a new war crime'.
The 16-year-old's body was found on January 16 on a pathway in Dinnington, South Yorkshire.